Praluzatamab ravtansine
CAS: 2145115-85-9
Ref. TM-T9901A
| 1mg | To inquire | ||
| 2mg | 444.00 € | ||
| 5mg | To inquire | ||
| 10mg | 1,031.00 € | ||
| 25mg | 1,570.00 € | ||
| 50mg | 2,108.00 € | ||
| 100mg | 2,751.00 € |
Estimated delivery in United States, on Thursday 14 Nov 2024
Product Information
Name:
Praluzatamab ravtansine
Synonyms:
- CX-2009
Description:
Sirtratumab vedotin (ASG15-ME) is an antibody-drug conjugate (ADC) that links a SLITRK6-specific human gamma 2 antibody (Igγ2) to the microtubule disruption agent monomethyl auristatin E (MMAE) through a protease-cleavable linker [1].
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Purity:
99.40%
Color/Form:
Soild
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T9901A Praluzatamab ravtansine
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
